A detailed history of Drive Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Drive Wealth Management, LLC holds 5,513 shares of ABBV stock, worth $1.11 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
5,513
Previous 5,526 0.24%
Holding current value
$1.11 Million
Previous $1.01 Million 6.06%
% of portfolio
0.26%
Previous 0.29%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$154.79 - $180.76 $2,012 - $2,349
-13 Reduced 0.24%
5,513 $945,000
Q1 2024

Apr 22, 2024

BUY
$159.82 - $182.1 $20,776 - $23,673
130 Added 2.41%
5,526 $1.01 Million
Q4 2023

Jan 22, 2024

SELL
$137.6 - $154.97 $2,064 - $2,324
-15 Reduced 0.28%
5,396 $836,000
Q3 2023

Oct 10, 2023

BUY
$133.59 - $154.65 $162,979 - $188,673
1,220 Added 29.11%
5,411 $806,000
Q2 2023

Jul 14, 2023

SELL
$132.51 - $164.9 $129,462 - $161,107
-977 Reduced 18.9%
4,191 $564,000
Q1 2023

Apr 13, 2023

BUY
$144.61 - $166.54 $52,638 - $60,620
364 Added 7.58%
5,168 $823,000
Q4 2022

Jan 27, 2023

BUY
$138.31 - $165.87 $166,110 - $199,209
1,201 Added 33.33%
4,804 $0
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $44,826 - $51,412
334 Added 10.22%
3,603 $484,000
Q2 2022

Nov 14, 2022

BUY
$137.62 - $174.96 $43,350 - $55,112
315 Added 10.66%
3,269 $501,000
Q1 2022

Nov 14, 2022

BUY
$131.98 - $163.75 $58,599 - $72,705
444 Added 17.69%
2,954 $479,000
Q4 2021

Nov 14, 2022

BUY
$107.43 - $135.93 $269,649 - $341,184
2,510 New
2,510 $340,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $356B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Drive Wealth Management, LLC Portfolio

Follow Drive Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Drive Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Drive Wealth Management, LLC with notifications on news.